Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) FCF Margin (2016 - 2025)

Dare Bioscience (DARE) has disclosed FCF Margin for 9 consecutive years, with 12845.98% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, FCF Margin rose 68635.0% year-over-year to 12845.98%, compared with a TTM value of 11971.39% through Sep 2025, up 1239659.0%, and an annual FY2024 reading of 49335.18%, up 5071902.0% over the prior year.
  • FCF Margin was 12845.98% for Q3 2025 at Dare Bioscience, down from 26404.31% in the prior quarter.
  • Across five years, FCF Margin topped out at 56241.46% in Q2 2024 and bottomed at 73320.34% in Q1 2024.
  • Average FCF Margin over 4 years is 4785.82%, with a median of 4068.09% recorded in 2023.
  • Peak annual rise in FCF Margin hit 5118688bps in 2025, while the deepest fall reached -2983715bps in 2025.
  • Year by year, FCF Margin stood at 84.49% in 2022, then crashed by -434bps to 451.18% in 2023, then crashed by -1526bps to 7336.58% in 2024, then plummeted by -75bps to 12845.98% in 2025.
  • Business Quant data shows FCF Margin for DARE at 12845.98% in Q3 2025, 26404.31% in Q2 2025, and 22133.46% in Q1 2025.